Diagnostic utility of serum CA-125 and MMP-9 as individual and combined biomarkers for endometriosis: a case-control study with hormonal profile assessment
Anaesthesia, Pain & Intensive Care · 05.03.2026 · 30 (4) · 411-418
DOI: 10.35975/apic.v30i4.3205 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Anaesthesia, Pain & Intensive Care, online erschienen am 05.03.2026. Verfasst von Zainab Basil Jabber und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Non-invasive biomarkers for endometriosis remain a clinical need. This study evaluated the diagnostic potential of serum CA-125 and MMP-9, individually and combined, alongside reproductive hormonal profiles in Iraqi women with endometriosis.
Methods
A case-control study was conducted on 60 laparoscopically confirmed endometriosis patients and 60 healthy controls. Serum CA-125 and MMP-9 were measured by ELISA, and prolactin, FSH, and LH were assessed using Cobas e411. Diagnostic accuracy was evaluated by ROC curve analysis.
Results
CA-125 (P = 0.012), MMP-9 (P = 0.015), prolactin (P = 0.0001), and FSH (P = 0.010) were significantly elevated in patients. Both markers increased with disease stage (P = 0.006 and P = 0.001, respectively). The combined CA 125/MMP-9 model yielded the highest AUC (0.716), with 65.0% sensitivity and 80.0% specificity.
Conclusion
The combined CA-125/MMP-9 panel showed moderate diagnostic accuracy, suggesting potential as a supplementary non-invasive tool, though further validation in larger cohorts is needed. Keywords: Endometriosis; CA-125; MMP-9; Biomarkers; ROC curve; Prolactin; FSH; Non-invasive diagnosis; ELISA; Case-control study Citation: Jabber ZB, Shemran KAA, Mohammed Hassan SF. Diagnostic utility of serum CA-125 and MMP-9 as individual and combined biomarkers for endometriosis: a case-control study with hormonal profile assessment. Anaesth. pain intensive care. 2026;30(4):419-432. DOI: 10.35975/apic.v30i4.3205 Receved: March 01, 2026; Revised: March 05, 2026; Accepted: March 25, 2026
Zitieren
APA
Jabber, Z. B., Shemran, K. A. A., & Hassan, S. F. M. (2026). Diagnostic utility of serum CA-125 and MMP-9 as individual and combined biomarkers for endometriosis: a case-control study with hormonal profile assessment. Anaesthesia, Pain & Intensive Care, 30(4), 411-418. https://doi.org/10.35975/apic.v30i4.3205
Vancouver
Jabber ZB, Shemran KAA, Hassan SFM. Diagnostic utility of serum CA-125 and MMP-9 as individual and combined biomarkers for endometriosis: a case-control study with hormonal profile assessment. Anaesthesia, Pain & Intensive Care. 2026;30(4):411-418. doi:10.35975/apic.v30i4.3205
BibTeX
@article{Jabber2026,
author = {Jabber, Zainab Basil and Shemran, Khawla Abed Alhamza and Hassan, Suhaila Fadhil Mohammed},
title = {Diagnostic utility of serum CA-125 and MMP-9 as individual and combined biomarkers for endometriosis: a case-control study with hormonal profile assessment},
journal = {Anaesthesia, Pain & Intensive Care},
year = {2026},
volume = {30},
number = {4},
pages = {411--418},
doi = {10.35975/apic.v30i4.3205}
}
EUVIMED